Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Oct 10 09:42AM ET
19.45
Dollar change
-0.19
Percentage change
-0.99
%
IndexRUT P/E- EPS (ttm)-2.90 Insider Own2.68% Shs Outstand69.93M Perf Week-0.13%
Market Cap1.36B Forward P/E- EPS next Y-3.28 Insider Trans-2.88% Shs Float68.05M Perf Month-7.93%
Income-177.37M PEG- EPS next Q-1.00 Inst Own89.91% Short Float7.87% Perf Quarter-1.29%
Sales133.62M P/S10.18 EPS this Y-91.04% Inst Trans-2.00% Short Ratio10.14 Perf Half Y-5.19%
Book/sh9.14 P/B2.13 EPS next Y17.43% ROA-22.11% Short Interest5.36M Perf Year0.49%
Cash/sh7.27 P/C2.68 EPS next 5Y- ROE-28.53% 52W Range15.31 - 26.84 Perf YTD-8.36%
Dividend Est.- P/FCF51.61 EPS past 5Y-9.81% ROI-27.55% 52W High-27.51% Beta0.67
Dividend TTM- Quick Ratio6.92 Sales past 5Y70.11% Gross Margin90.70% 52W Low27.07% ATR (14)0.80
Dividend Ex-Date- Current Ratio6.92 EPS Y/Y TTM-35.72% Oper. Margin-128.78% RSI (14)49.07 Volatility3.05% 4.06%
Employees280 Debt/Eq0.16 Sales Y/Y TTM17.84% Profit Margin-132.74% Recom1.55 Target Price31.10
Option/ShortYes / Yes LT Debt/Eq0.14 EPS Q/Q-191.34% Payout- Rel Volume0.28 Prev Close19.65
Sales Surprise-15.20% EPS Surprise-28.78% Sales Q/Q-62.74% EarningsAug 05 AMC Avg Volume528.53K Price19.45
SMA20-3.76% SMA505.09% SMA200-5.42% Trades Volume11,799 Change-0.99%
Date Action Analyst Rating Change Price Target Change
Apr-16-24Reiterated BTIG Research Buy $56 → $38
Feb-28-24Downgrade Piper Sandler Overweight → Neutral $37 → $24
May-19-23Initiated BofA Securities Buy $42
Dec-06-22Initiated Cowen Outperform
Oct-13-22Upgrade Raymond James Outperform → Strong Buy $58
Sep-21-22Initiated JP Morgan Overweight $37
Jul-06-22Resumed Canaccord Genuity Buy $50
Feb-11-22Initiated BMO Capital Markets Outperform $54
Jan-21-22Initiated SMBC Nikko Outperform $60
Dec-15-21Initiated H.C. Wainwright Buy $61
Today 08:09AM
Oct-04-24 08:01AM
Sep-12-24 04:01PM
04:55AM
Sep-11-24 06:31AM
04:01PM Loading…
Sep-10-24 04:01PM
Sep-09-24 07:31AM
Sep-06-24 08:01AM
Aug-05-24 09:55PM
05:15PM
04:12PM
04:01PM
Jun-13-24 08:01AM
May-10-24 01:45PM
06:20AM
11:54PM Loading…
May-09-24 11:54PM
05:18PM
04:09PM
May-06-24 10:00AM
May-03-24 07:01PM
May-02-24 03:31AM
Apr-09-24 08:01AM
Mar-08-24 05:01PM
Mar-07-24 05:00PM
Feb-28-24 04:01PM
09:35AM
08:38AM
Feb-27-24 05:20PM
04:39PM
04:26PM
04:01PM Loading…
04:01PM
Feb-20-24 04:31PM
Feb-19-24 03:37AM
Feb-15-24 10:00AM
Jan-03-24 04:01PM
09:55AM
Jan-02-24 08:01AM
Dec-30-23 05:02PM
Nov-21-23 04:01PM
Nov-09-23 02:19PM
Nov-08-23 05:21AM
Nov-07-23 04:39PM
04:01PM
04:01PM
Nov-03-23 12:01PM
Oct-31-23 04:01PM
12:00PM
Oct-26-23 08:01AM
Oct-17-23 04:21AM
Sep-27-23 09:01AM
Sep-19-23 04:01PM
Aug-08-23 06:01AM
Aug-07-23 04:02PM
Aug-03-23 05:15PM
04:13PM
04:01PM
Jul-27-23 08:01AM
Jul-03-23 08:38PM
Jun-21-23 08:00PM
Jun-18-23 10:00AM
May-30-23 06:01PM
May-09-23 01:49PM
May-08-23 05:15PM
04:08PM
04:01PM
May-01-23 04:01PM
Apr-26-23 08:00PM
08:01AM
Apr-17-23 01:31PM
Apr-09-23 01:19PM
Mar-14-23 04:31PM
02:56AM
Feb-28-23 05:10AM
Feb-25-23 07:17AM
Feb-23-23 05:25PM
04:01PM
Feb-20-23 10:00AM
Feb-16-23 04:01PM
Feb-07-23 04:01PM
Jan-26-23 02:33PM
Jan-09-23 08:01AM
Jan-05-23 06:30AM
Jan-04-23 04:01PM
Dec-12-22 03:44PM
10:00AM
Nov-30-22 09:55AM
Nov-25-22 12:00PM
Nov-10-22 04:01PM
09:55AM
09:01AM
Nov-07-22 05:25PM
04:01PM
04:01PM
Nov-03-22 09:01AM
Oct-31-22 04:01PM
Oct-28-22 11:58AM
Oct-14-22 09:41AM
Oct-06-22 08:37PM
Oct-05-22 08:01AM
Sep-09-22 08:01AM
Xencor, Inc. is a biopharmaceutical company, which engages in the development of engineered monoclonal antibody therapeutics to treat severe and life-threatening diseases. Its proprietary technology platform, XmAb, is used to create next-generation antibody product candidates designed to treat autoimmune and allergic diseases, cancer, and other conditions. The company was founded by Bassil I. Dahiyat and Stephen L. Mayo in August 1997 and is headquartered in Monrovia, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ROSA-BJORKESON DAGMARDirectorSep 27 '24Sale20.682,50351,7628,490Oct 01 04:13 PM
RANIERI RICHARD JDirectorSep 27 '24Sale20.682,50351,7628,490Oct 01 04:12 PM
GUSTAFSON KURT ADirectorSep 27 '24Sale20.682,50351,7629,490Oct 01 04:10 PM
GORMAN KEVIN CHARLESDirectorSep 27 '24Sale20.682,65454,8858,392Oct 01 04:09 PM
Montgomery Alan BruceDirectorSep 27 '24Sale20.681,85338,3209,140Oct 01 04:08 PM
Feigal EllenDirectorSep 27 '24Sale20.682,50351,7628,490Oct 01 04:07 PM
GORMAN KEVIN CHARLESDirectorSep 27 '24Proposed Sale20.682,65454,885Sep 27 10:58 AM
Montgomery Alan BruceDirectorSep 27 '24Proposed Sale20.681,85338,320Sep 27 10:39 AM
Feigal EllenDirectorSep 27 '24Proposed Sale20.682,50351,762Sep 27 10:35 AM
RANIERI RICHARD JDirectorSep 27 '24Proposed Sale20.682,50351,762Sep 27 10:29 AM
GUSTAFSON KURT ADirectorSep 27 '24Proposed Sale20.682,50351,762Sep 27 10:12 AM
ROSA-BJORKESON DAGMARDirectorSep 27 '24Proposed Sale20.682,50351,762Sep 27 09:41 AM
Desjarlais John RSR. VICE PRESIDENT & CSOJul 09 '24Option Exercise10.7342,215452,967228,648Jul 11 06:41 PM
Desjarlais John RSR. VICE PRESIDENT & CSOJul 10 '24Option Exercise10.737,78583,533200,104Jul 11 06:41 PM
Desjarlais John RSR. VICE PRESIDENT & CSOJul 09 '24Sale18.3236,329665,511192,319Jul 11 06:41 PM
Valente NancyEVP, Chief Development OfficerMay 02 '24Sale23.584,745111,87255,115May 03 04:06 PM
Kuch John JSR. VICE PRESIDENT & CFOMar 11 '24Sale23.5084919,953121,070Mar 12 04:08 PM
Eckert CeliaSVP, GENERAL COUNSELMar 11 '24Sale23.5085019,97745,465Mar 12 04:06 PM
Desjarlais John RSR. VICE PRESIDENT & CSOMar 11 '24Sale23.501,28030,082186,433Mar 12 04:05 PM
Dahiyat Bassil IPRESIDENT & CEOMar 11 '24Sale23.502,74164,418351,894Mar 12 04:03 PM
GUSTAFSON KURT ADirectorMar 06 '24Option Exercise10.7315,000160,95020,007Mar 07 04:10 PM
GUSTAFSON KURT ADirectorMar 06 '24Sale23.1814,000324,4536,007Mar 07 04:10 PM
Kuch John JSR. VICE PRESIDENT & CFOMar 05 '24Sale23.434,474104,821121,919Mar 07 04:07 PM
Desjarlais John RSR. VICE PRESIDENT & CSOMar 05 '24Sale23.436,629155,311166,989Mar 07 04:05 PM
Eckert CeliaSVP, GENERAL COUNSELMar 05 '24Sale23.433,89291,18633,226Mar 07 04:03 PM
Dahiyat Bassil IPRESIDENT & CEOMar 05 '24Sale23.4312,528293,519300,097Mar 07 04:01 PM
Desjarlais John RSR. VICE PRESIDENT & CSOFeb 14 '24Option Exercise11.0511,943131,970173,618Feb 16 04:06 PM
GORMAN KEVIN CHARLESDirectorFeb 13 '24Buy19.12531,0135,060Feb 15 04:02 PM
Desjarlais John RSR. VICE PRESIDENT & CSOFeb 13 '24Option Exercise11.0568,057752,030215,783Feb 14 02:23 PM
Desjarlais John RSR. VICE PRESIDENT & CSOFeb 13 '24Sale19.3854,1081,048,743161,675Feb 14 02:23 PM
Dahiyat Bassil IPRESIDENT & CEODec 29 '23Option Exercise11.0565,001718,261357,929Dec 29 04:24 PM
Dahiyat Bassil IPRESIDENT & CEODec 29 '23Sale20.9345,000941,670312,929Dec 29 04:24 PM